Trial intelligence / Profile preview

Adding Methotrexate to Etanercept in Moderate to Severe Plaque Psoriasis

NCT01001208Phase 3Completed

Sponsor
Amgen
Start
Nov 2009
Primary completion
Dec 2010
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of methotrexate in plaque psoriasis, sponsored by Amgen. Started Nov 2009; status: completed.

02

Drugs

methotrexate
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01001208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01001208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call